Home › NDC Lookup › RxCUI directory › RxCUI 2704986

{6 (nirmatrelvir 150 MG Oral Tablet) / 5 (ritonavir 100 MG Oral Tablet) } Pack — RxCUI 2704986

RxNorm drug concept · Generic pack
RxCUI 2704986 Generic pack · GPCK ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2704986
Official name{6 (nirmatrelvir 150 MG Oral Tablet) / 5 (ritonavir 100 MG Oral Tablet) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asnirmatrelvir 150 MG Oral Tablet (6) / ritonavir 100 MG Oral Tablet (5) 300 MG /100 MG ; 150 MG / 100 MG Dose Pack; nirmatrelvir / ritonavir 300 MG /100 MG ; 150 MG / 100 MG Dose Pack
FDA products mapped6
Package NDCs mapped6
Reported Medicaid activity (SDUD)151,858 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ritonavir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ritonavir must always be used with other HIV medicines — that's how it's approved and how it works best. HIV treatment is a combination approach because using just one drug gives t...
  • Why do I have to take ritonavir with other HIV medicines — can't I just take it alone?
  • Yes, stomach side effects are actually the most common complaint with ritonavir — things like nausea, diarrhea, vomiting, and stomach pain are reported by a large number of people...
  • I'm getting a lot of nausea and diarrhea. Is that normal, and will it get better?
📖 Read our full Ritonavir guide →

🕸️ Concept Web — How {6 (nirmatrelvir 150 MG Oral Tablet) / 5 (ritona... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {6 (nirmatrelvir 150 MG Oral Tablet) / 5 (ritonavir 100 MG Oral Tablet) } Pack RxCUI 2704986

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Nirmatrelvir 2587892
    • Ritonavir 85762
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Norvir 196479
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nirmatrelvir Oral Tablet 2587896
    • Ritonavir Oral Tablet 900574
    • Nirmatrelvir Oral Product 2587894
    • Nirmatrelvir Pill 2587895
    • Ritonavir Oral Product 1165486
    • Ritonavir Pill 1165487
    • Ritonavir Oral Tablet [Norvir] 900576
    • Norvir Oral Product 1177579
    • +4 more in this family
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 18 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nirmatrelvir 150 MG Oral Tablet SCD · 2587897
  • Ritonavir 100 MG Oral Tablet SCD · 900575
  • Nirmatrelvir 150 MG SCDC · 2587893
  • Ritonavir 100 MG SCDC · 317488
  • Nirmatrelvir Oral Tablet SCDF · 2587896
  • Ritonavir Oral Tablet SCDF · 900574
  • Nirmatrelvir Oral Product SCDG · 2587894
  • Nirmatrelvir Pill SCDG · 2587895
  • Ritonavir Oral Product SCDG · 1165486
  • Ritonavir Pill SCDG · 1165487

Brand-Name Concepts

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 2704986 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00069-0521-11 1 BLISTER PACK in 1 CARTON (0069-0521-11) / 1 KIT in 1 BLIS... Paxlovid Pfizer Laboratories Div Pfizer Inc 2025-04-15
00069-5045-30 10 BLISTER PACK in 1 CARTON (0069-5045-30) / 1 KIT in 1 BLI... Paxlovid Pfizer Laboratories Div Pfizer Inc 2025-07-09
00069-5317-20 10 BLISTER PACK in 1 CARTON (0069-5317-20) / 1 KIT in 1 BLI... Paxlovid Pfizer Laboratories Div Pfizer Inc 2023-10-18
00069-5321-30 10 BLISTER PACK in 1 CARTON (0069-5321-30) / 1 KIT in 1 BLI... Paxlovid Pfizer Laboratories Div Pfizer Inc 2023-10-18
00069-5434-20 10 BLISTER PACK in 1 CARTON (0069-5434-20) / 1 KIT in 1 BLI... Paxlovid Pfizer Laboratories Div Pfizer Inc 2025-07-09
00069-5450-11 1 BLISTER PACK in 1 CARTON (0069-5450-11) / 1 KIT in 1 BLIS... Paxlovid Pfizer Laboratories Div Pfizer Inc 2026-01-05
Observed labelers: Pfizer Laboratories Div Pfizer Inc (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.